Status:

TERMINATED

Temporal Interference Neurostimulation and Addiction

Lead Sponsor:

Indiana University

Collaborating Sponsors:

Indiana University School of Medicine

Conditions:

Nicotine Use Disorder

Substance Use Disorders

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

This project aims to develop a line of research using new non-invasive neurostimulation technology to treat adults with opioid use disorders (OUDs). In the short term, the investigators aim to identif...

Detailed Description

The investigators hypothesize that temporal interference non-invasive deep brain stimulation (TI-NDBS) will be well tolerated and effective at manipulating brain activity and reducing drug cravings. T...

Eligibility Criteria

Inclusion

  • Must be between the ages of 18 and 50, must have at least 6th grade education, and the ability to speak and read English, must smoke at least 3/4 of a pack of cigarettes per day, must have phone with internet access.

Exclusion

  • if they are on psychotropic medications for ADHD, other mental illness or medication for cancer, epilepsy (i.e. individuals with any history of seizure disorder), migraines, or other neurological syndromes, or AIDs (which can cause cognitive deficits (Watkins \& Treisman, 2015), history of head trauma, history of cognitive impairments, metal implants in the head or under the scalp, personal experiences consistent with symptoms of psychosis (i.e. mind or body being secretly controlled, special powers, seeing or hearing things that aren't really there).
  • Subjects will be excluded if they do not meet fMRI safety screening criteria (i.e. metal implants in their body, tattoo on head or neck, permanent jewelry, etc.) or if a participant uses an IUD for birth control they will be excluded unless the subject can document the model of the IUD and we can verify its safety for the MRI environment. Pregnancy should be self-reported, and a pregnancy test will not be administered. Participants must also weigh less than 440 lbs.
  • History of holes bored into skull or known fissures in cranial bones
  • Presence of pacemakers

Key Trial Info

Start Date :

July 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 21 2022

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04432064

Start Date

July 6 2020

End Date

April 21 2022

Last Update

June 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University

Bloomington, Indiana, United States, 47403